Other languages CERo Therapeutics Holdings, Inc.

Equities

CERO

US71902K1051

Market Closed - Nasdaq Other stock markets 01:30:00 22/06/2024 am IST			5-day change	1st Jan Change
0.3452 ^USD	+19.03%		-9.13%	-96.86%

06/06	CERo Therapeutics, Inc. Successfully Completes IND-Enabling Toxicology Studies for Lead Compound CER-1236	CI
17/05	CERo Therapeutics Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Other languages

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

CERo Therapeutics, Inc. Successfully Completes IND-Enabling Toxicology Studies for Lead Compound CER-1236	06/06
CERo Therapeutics Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	18/05
CERo Therapeutics Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	02/04
Top Premarket Decliners	11/03
Top Premarket Gainers	08/03
CERo Therapeutics, Inc. Announces Publication of Preclinical Research Supporting the Use of its Clinical Candidate CER-1236 to Treat AML Patients	07/03
Top Premarket Decliners	20/02
Phoenix Biotech Acquisition Completes Merger With CERo Therapeutics	15/02
Phoenix Biotech Acquisition Corp. Appoints Brian Atwood as Chief Executive Officer	15/02
Phoenix Biotech Acquisition Corp. Announces Executive and Board Changes	15/02
Phoenix Biotech Acquisition Corp. completed the acquisition of CERo Therapeutics, Inc.	14/02
Phoenix Biotech Acquisition Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	10/11
Phoenix Biotech Acquisition Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	15/23/15
Phoenix Biotech Acquisition Corp. Reports Earnings Results for the First Quarter Ended March 31, 2023	13/23/13
Phoenix Biotech Acquisition Corp. Reports Earnings Results for the Full Year Ended December 31, 2022	24/23/24
Phoenix Biotech Acquisition Corp. Reports Earnings Results for the Full Year Ended December 31, 2022	24/23/24
Phoenix Biotech Acquisition Corp. cancelled the acquisition of Intrinsic Medicine, Inc. from Phoenix Biotech Sponsor, LLC, Beryl Capital Management LLC, Highbridge Capital Management, LLC, Saba Capital Management, L.P. and others.	06/22/06
Phoenix Biotech Acquisition Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	11/22/11
Phoenix Biotech Acquisition Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	12/22/12
Phoenix Biotech Acquisition Corp. Reports Earnings Results for the First Quarter Ended March 31, 2022	14/22/14

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages CERo Therapeutics Holdings, Inc.

Equities

CERO

US71902K1051

Other languages

Filters